Key Takeaways
- • Brevan Howard's flagship Master Fund returned only +0.8% in 2025, dramatically underperforming peers amid a record $543 billion macro hedge-fund industry gain, with competitors like Bridgewater (+33%) and Discovery Capital (+36%) posting double-digit returns.
- • The firm suffered a 2.93% loss in January 2025 alone due to failed interest-rate and FX positioning, signaling systematic strategic missteps during a period of unprecedented volatility driven by geopolitical tensions, Fed policy shifts, and Trump-era tariff announcements.
- • Brevan Howard is closing the $1.4 billion Brevan Howard FG Fund, run by Fash Golchin, by end-June 2026, as weak 2025 performance triggers internal restructuring focused on the flagship Master Fund.
- • Company profits fell 20.7% to £294.3 million for the year to March 2025, reflecting the fund's inability to capitalize on a market environment rich with trading opportunities that benefited competitors across macro, duration, and value-driven strategies.
- • Smaller and more specialized macro managers—including Rokos Capital (+21%) and D.E. Shaw's macro arm (~28%)—significantly outpaced Brevan Howard's returns, suggesting competitive erosion in the firm's core macro expertise.
Summary
Brevan Howard experienced a marked performance collapse in 2025, failing to participate meaningfully in what proved to be a banner year for macro hedge funds. While the broader hedge-fund industry generated an estimated $543 billion in gains—an all-time record—Brevan Howard's flagship Master Fund eked out just +0.8%, with its Alpha Strategies subsidiary managing only +8.0%. This stark underperformance during an environment explicitly suited to macro trading represents a significant strategic failure for the $33 billion asset manager.
The year's macro trading opportunity set was exceptionally rich. Unprecedented volatility stemming from ongoing geopolitical conflicts, fraying supply chains, aggressive Federal Reserve policy pivots, and political shocks—including President Trump's renewed tariff threats—created exactly the conditions historically favorable to discretionary macro traders. Competitors capitalized aggressively: Bridgewater's Pure Alpha fund posted approximately +33%, Discovery Capital's macro fund returned around +36%, and even smaller specialized managers like Rokos Capital (+21%) and D.E. Shaw's macro arm (~28%) crushed Brevan Howard's results. Sir Chris Hohn's TCI Fund Management alone captured $18.9 billion of the industry's record gains.
Brevan Howard's losses were concentrated early. In January 2025 alone, the Master Fund declined 2.93%, erasing most prior-year gains as interest-rate hedging and foreign exchange positions deteriorated. This rapid deterioration suggests the firm's traders bet incorrectly on key directional moves during a period when volatility should have rewarded precise positioning. Meanwhile, competitors' strategies—from Bridgewater's duration bets to Discovery's value-oriented calls—systematically exploited market dislocations that Brevan Howard missed.
The performance shortfall is already forcing structural changes. Brevan Howard announced it will close the $1.4 billion Brevan Howard FG Fund, managed by Fash Golchin since 2018, by end-June 2026, with the decision reflecting management's decision to focus external capital exclusively on the flagship fund. Company profits declined 20.7% to £294.3 million for the year to March 2025, compounding investor pressure. These moves signal recognition that fundamental strategic gaps prevented the firm from executing successfully during an environment explicitly designed to reward macro expertise—a development with potential implications for asset retention and competitive positioning among institutional allocators.
The year's macro trading opportunity set was exceptionally rich. Unprecedented volatility stemming from ongoing geopolitical conflicts, fraying supply chains, aggressive Federal Reserve policy pivots, and political shocks—including President Trump's renewed tariff threats—created exactly the conditions historically favorable to discretionary macro traders. Competitors capitalized aggressively: Bridgewater's Pure Alpha fund posted approximately +33%, Discovery Capital's macro fund returned around +36%, and even smaller specialized managers like Rokos Capital (+21%) and D.E. Shaw's macro arm (~28%) crushed Brevan Howard's results. Sir Chris Hohn's TCI Fund Management alone captured $18.9 billion of the industry's record gains.
Brevan Howard's losses were concentrated early. In January 2025 alone, the Master Fund declined 2.93%, erasing most prior-year gains as interest-rate hedging and foreign exchange positions deteriorated. This rapid deterioration suggests the firm's traders bet incorrectly on key directional moves during a period when volatility should have rewarded precise positioning. Meanwhile, competitors' strategies—from Bridgewater's duration bets to Discovery's value-oriented calls—systematically exploited market dislocations that Brevan Howard missed.
The performance shortfall is already forcing structural changes. Brevan Howard announced it will close the $1.4 billion Brevan Howard FG Fund, managed by Fash Golchin since 2018, by end-June 2026, with the decision reflecting management's decision to focus external capital exclusively on the flagship fund. Company profits declined 20.7% to £294.3 million for the year to March 2025, compounding investor pressure. These moves signal recognition that fundamental strategic gaps prevented the firm from executing successfully during an environment explicitly designed to reward macro expertise—a development with potential implications for asset retention and competitive positioning among institutional allocators.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.